KayoThera
San Diego, United States· Est.
PIONEERING FIRST-IN-CLASS ANTAGONISTS OF THE RETINOID NUCLEAR RECEPTOR PATHWAY FOR UNMET MEDICAL NEEDS
Private Company
Total funding raised: $30M
About
PIONEERING FIRST-IN-CLASS ANTAGONISTS OF THE RETINOID NUCLEAR RECEPTOR PATHWAY FOR UNMET MEDICAL NEEDS
Small Molecules
Funding History
2Total raised:$30M
Series A$25M
Seed$5M